Dorui Pharmaceutical (301075.SZ) plans to sell no more than 1.044,500 shares already purchased

Zhitong Financial App News, Dorui Pharmaceutical (301075.SZ) announced that the board of directors of the company reviewed and passed the “Proposal on the Centralized Auction and Reduction Plan for Repurchase Shares”. According to the use agreement of the “Repurchase Report” disclosed by the company on February 8, 2024, it was agreed that the company would sell the repurchased shares through centralized bidding. The implementation period is 6 months from the date of disclosure of this announcement (that is, from January 14, 2026 to July 13, 2026, except for the period prohibited from sale according to the relevant regulations of the China Securities Regulatory Commission and the Shenzhen Stock Exchange) No more than 1.044,500 shares were sold and repurchased, accounting for 1.31% of the company's total share capital. The sale price was determined based on the secondary market price.